{"schema_version":"secwatch.filing_event.v1","accession":"0001823239-21-000018","form_type":"8-K","ticker":"MRVI","cik":"0001823239","company_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","filed_at":"2021-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.885382+00:00","generated_at":"2026-06-29T17:17:43.782493+00:00","sec_items":["1.01","2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Maravai Q2 revenue up 364% to $217.8M, raises FY guidance to $745-770M; selling Vector for $124M","bullets":["Q2 revenue $217.8M (+364% YoY); net income $134.3M vs $1.4M; Adj. EBITDA $164.7M vs $17.5M.","Nucleic Acid Production revenue $192.5M (+532.8% YoY) driven by CleanCap demand for COVID-19 vaccines.","Divested Protein Detection segment (Vector) for $124M cash to Thompson Street Capital Partners; close expected Q3 2021.","2021 revenue guidance raised to $745-770M from prior; reflects robust demand for Nucleic Acid Production.","Facility expansions: new San Diego site to boost mRNA capacity; Biologic Safety Testing moving to larger Leland, NC site."],"urls":{"canonical":"https://secwatch.observer/filing/0001823239-21-000018","json":"https://secwatch.observer/filing/0001823239-21-000018.json","markdown":"https://secwatch.observer/filing/0001823239-21-000018.md","text":"https://secwatch.observer/filing/0001823239-21-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1823239/000182323921000018/0001823239-21-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1823239/000182323921000018/mrvi-20210805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T17:17:43.782493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}